(Q39758653)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Bullous pemphigoid controlled by tetracycline (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

1 reference

C R Thornfeldt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

A W Menkes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

language of work or name

English

0 references

publication date

1 February 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

2 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

305-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Bullous pemphigoid:therapy in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Benign pemphigold; a report of seven cases with chronic, scarring, herpetiform plaques about the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Coexistence of localized bullous pemphigoid, morphea, and subcorneal pustulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Localized chronic pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

1 reference

7 January 2021

Brunsting-Perry cicatricial pemphigoid associated with bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Immunohistochemistry of Ultraviolet-Induced Pemphigus and Pemphigoid Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Lesions induced by trauma in pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

The effect of antimicrobial agents on leukocyte chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Anti-Inflammatory Effects Of Antimicrobial Agents: An In Vivo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Effects of tetracycline on leukotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Effect of antibiotics of chemotaxis of human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Antibiotics and suppression of lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Pyoderma gangrenosum: successful treatment with minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Demethylchlortetracycline and griseofulvin as examples of specific treatment for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

Mycosis fungoides responding to tetracycline and griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970040-1

7 January 2021

10.1016/S0190-9622(87)70040-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3546415%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference